Correlation Between Sonnet Biotherapeutics and Hepion Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Sonnet Biotherapeutics and Hepion Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Sonnet Biotherapeutics and Hepion Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Sonnet Biotherapeutics Holdings and Hepion Pharmaceuticals, you can compare the effects of market volatilities on Sonnet Biotherapeutics and Hepion Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Sonnet Biotherapeutics with a short position of Hepion Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Sonnet Biotherapeutics and Hepion Pharmaceuticals.
Diversification Opportunities for Sonnet Biotherapeutics and Hepion Pharmaceuticals
0.6 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Sonnet and Hepion is 0.6. Overlapping area represents the amount of risk that can be diversified away by holding Sonnet Biotherapeutics Holding and Hepion Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Hepion Pharmaceuticals and Sonnet Biotherapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Sonnet Biotherapeutics Holdings are associated (or correlated) with Hepion Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Hepion Pharmaceuticals has no effect on the direction of Sonnet Biotherapeutics i.e., Sonnet Biotherapeutics and Hepion Pharmaceuticals go up and down completely randomly.
Pair Corralation between Sonnet Biotherapeutics and Hepion Pharmaceuticals
Given the investment horizon of 90 days Sonnet Biotherapeutics Holdings is expected to generate 0.56 times more return on investment than Hepion Pharmaceuticals. However, Sonnet Biotherapeutics Holdings is 1.77 times less risky than Hepion Pharmaceuticals. It trades about -0.1 of its potential returns per unit of risk. Hepion Pharmaceuticals is currently generating about -0.1 per unit of risk. If you would invest 285.00 in Sonnet Biotherapeutics Holdings on November 18, 2024 and sell it today you would lose (126.00) from holding Sonnet Biotherapeutics Holdings or give up 44.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Sonnet Biotherapeutics Holding vs. Hepion Pharmaceuticals
Performance |
| Timeline |
| Sonnet Biotherapeutics |
| Hepion Pharmaceuticals |
Sonnet Biotherapeutics and Hepion Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Sonnet Biotherapeutics and Hepion Pharmaceuticals
The main advantage of trading using opposite Sonnet Biotherapeutics and Hepion Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Sonnet Biotherapeutics position performs unexpectedly, Hepion Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Hepion Pharmaceuticals will offset losses from the drop in Hepion Pharmaceuticals' long position.| Sonnet Biotherapeutics vs. ZyVersa Therapeutics | Sonnet Biotherapeutics vs. Allarity Therapeutics | Sonnet Biotherapeutics vs. Immix Biopharma | Sonnet Biotherapeutics vs. Cns Pharmaceuticals |
| Hepion Pharmaceuticals vs. Enveric Biosciences | Hepion Pharmaceuticals vs. Elevation Oncology | Hepion Pharmaceuticals vs. Ocean Biomedical | Hepion Pharmaceuticals vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |